Athyrium Opportunities News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Athyrium Opportunities. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Athyrium Opportunities Today - Breaking & Trending Today

Kala Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update

Published: March 3, 2023

-- Enrolled first patient in CHASE Phase 2b clinical trial evaluating KPI-012 for PCED; Top-line data targeted for 1Q 2024 -- -- Closed $31.0 million... | March 3, 2023

Source: marketscreener.com

Related Topics:

United StatesMark IwickiHannah DeresiewiczDrug AdministrationKala Pharmaceuticals IncExchange CommissionSee The CompanyAlcon IncOxford FinanceKala PharmaceuticalsCombangio IncChief Executive OfficerRecent Business HighlightsStage PipelineCorneal Healing AfterBiologics License ApplicationOrphan Drug DesignationLimbal Stem Cell DeficiencyRetinitis PigmentosaProduct RevenuesFair Value RemeasurementDeferred Purchase ConsiderationContingent ConsiderationFull YearAthyrium Opportunities